Open Access Highly Accessed Open Badges Review

Diacylglycerol oil for the metabolic syndrome

Hidekatsu Yanai1*, Yoshiharu Tomono1, Kumie Ito1, Nobuyuki Furutani1, Hiroshi Yoshida2 and Norio Tada1

Author Affiliations

1 Department of Internal Medicine, The Jikei University School of Medicine, Chiba, Japan

2 Department of Laboratory Medicine, The Jikei University School of Medicine, Chiba, Japan

For all author emails, please log on.

Nutrition Journal 2007, 6:43  doi:10.1186/1475-2891-6-43

Published: 11 December 2007


Excess adiposity has been shown to play a crucial role in the development of the metabolic syndrome. The elevated fasting and postprandial triglyceride-rich lipoprotein levels is the central lipid abnormality observed in the metabolic syndrome. Recent studies have indicated that diacylglycerol (DAG) is effective for fasting and postprandial hyperlipidemia and preventing excess adiposity by increasing postprandial energy expenditure. We will here discuss the mechanisms of DAG-mediated improvements in hyperlipidemia and in postprandial energy expenditure, and effects of DAG oil on lipid/glucose metabolism and on body fat. Further, the therapeutic application of DAG for the metabolic syndrome will be considered.